Like what you've read?

On Line Opinion is the only Australian site where you get all sides of the story. We don't
charge, but we need your support. Here�s how you can help.

  • Advertise

    We have a monthly audience of 70,000 and advertising packages from $200 a month.

  • Volunteer

    We always need commissioning editors and sub-editors.

  • Contribute

    Got something to say? Submit an essay.


 The National Forum   Donate   Your Account   On Line Opinion   Forum   Blogs   Polling   About   
On Line Opinion logo ON LINE OPINION - Australia's e-journal of social and political debate

Subscribe!
Subscribe





On Line Opinion is a not-for-profit publication and relies on the generosity of its sponsors, editors and contributors. If you would like to help, contact us.
___________

Syndicate
RSS/XML


RSS 2.0

Innovation the loser from book 'expropriation'

By Alan Moran - posted Wednesday, 29 July 2009


International price differentials are vital to the-present arrangements in profitably developing new drugs.

Pharmaceutical firms have historically earned high prices in the unregulated US market but are often forced to accept lower prices where buyer monopolies are in place, as in Australia arid Canada. And the-firms themselves, for humanitarian reasons or simply to maximise profits, will often sell patented products at cheaper prices to Third World countries.

Increasingly, price, convergence undermines this. Once the products can be imported (or, as is often the case, re-imported) into the US, multiple prices are replaced by a single-price structure. Where this results in the US price becoming the sole price, customers outside the US will pay more and the supplier will see reduced sales. If prices shift towards those in the lower-priced markets, volumes will rise, though at the expense of profits.

Advertisement

Copyright owners of books and CDs may well have to acquiesce in the erosion of parallel importing protections and the reduced innovation incentive this entails. For pharmaceutical firms, market segmentation and price discrimination is even more important. The end of price discrimination would require revolutionary changes in their approach to research and development.

  1. Pages:
  2. 1
  3. Page 2
  4. All

First published in The Weekend Australian Financial Review on July 18, 2009.

Advertisement
 Institute of Public Affairs Advertisement

 

Discuss in our Forums

See what other readers are saying about this article!

Click here to read & post comments.

9 posts so far.

Share this:
reddit this reddit thisbookmark with del.icio.us Del.icio.usdigg thisseed newsvineSeed NewsvineStumbleUpon StumbleUponsubmit to propellerkwoff it

About the Author

Alan Moran is the principle of Regulatory Economics.

Other articles by this Author

All articles by Alan Moran

Creative Commons LicenseThis work is licensed under a Creative Commons License.

Photo of Alan Moran
Article Tools
Comment 9 comments
Print Printable version
Subscribe Subscribe
Email Email a friend
Latest from Institute of Public Affairs
 No reality holiday from this population challenge
 For budgets only smaller is tougher
 Government subsidies to green groups must end
 Boot-strapping on a carbon tax
 West's history not complete without reference to Christianity
 More...
Advertisement

About Us Search Discuss Feedback Legals Privacy